DEADLINE APPROACHING: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Oracle Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Sat Jun 25, 4:41PM CDT
IRVINE, CA / ACCESSWIRE / June 25, 2016 / Khang & Khang LLP (the "Firm"
ORCL: 40.83 (+0.82)
SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Oracle Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Fri Jun 24, 3:45PM CDT
Khang & Khang LLP (the "Firm"
ORCL: 40.83 (+0.82)
Q2 Earnings Season Gets Underway
Sheraz Mian - Zacks Investment Research - Fri Jun 24, 3:40PM CDT
Q2 Earnings Season Gets Underway
FDX: 157.89 (+1.38), AA: 10.15 (+0.26), ADBE: 96.21 (+2.20), ORCL: 40.83 (+0.82)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oracle Corporation of Class Action Lawsuit and Upcoming Deadline - ORCL
GlobeNewswire - Fri Jun 24, 3:15PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed on behalf of Oracle Corporation ("Oracle" or the "Company"
ORCL: 40.83 (+0.82)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Oracle Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - ORCL
GlobeNewswire - Fri Jun 24, 11:23AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ORCL: 40.83 (+0.82)
Oracle Corporation Stock Will Rise As Cloud Revenue Soars
Arie Goren - Amigobulls - Wed Jun 22, 5:10AM CDT
Oracle Corporation (NYSE:ORCL) reported strong growth in its cloud revenue segment and also upped its cloud segment guidance. Is Oracle stock a buy now?
ORCL: 40.83 (+0.82)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Oracle Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Tue Jun 21, 4:02PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Oracle Corporation ("Oracle" or the "Company"
ORCL: 40.83 (+0.82)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Oracle Corporation (ORCL) and Lead Plaintiff Deadline: August 1, 2016
ACCESSWIRE - Tue Jun 21, 9:10AM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Oracle Corporation ("Oracle" or "the Company"
ORCL: 40.83 (+0.82)
Salesforce-Demandware Deal Ok'd, HSR Waiting Period Pared
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:56AM CDT
Salesforce.com Inc.'s (CRM) acquisition of Demandware Inc. (DWRE), a provider of software-as-a-service e-commerce solutions, took a step ahead yesterday with an important regulatory approval by the U.S. Federal Trade Commission.
SAP: 81.07 (+2.24), DWRE: 74.91 (+0.02), ORCL: 40.83 (+0.82), CRM: 82.28 (+1.66)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Oracle Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - ORCL
ACCESSWIRE - Mon Jun 20, 9:45AM CDT
NEW YORK, NY / ACCESSWIRE / June 20, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ORCL: 40.83 (+0.82)
Zacks Earnings Trends Highlights: Costco, AutoZone, Oracle, Adobe and FedEx
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:30AM CDT
Zacks Earnings Trends Highlights: Costco, AutoZone, Oracle, Adobe and FedEx
FDX: 157.89 (+1.38), AZO: 762.77 (+6.47), COST: 157.03 (-1.09), ADBE: 96.21 (+2.20), ORCL: 40.83 (+0.82)
Oracle Announces Pfizer's Selection of Oracle Cloud for Clinical Data Management and Trial Management Across Its Clinical Trial Portfolio
Marketwire Canada - Mon Jun 20, 7:01AM CDT
REDWOOD SHORES, CA--(Marketwired - Jun 20, 2016) - Oracle today announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service to help manage and monitor its more than 300 clinical trials a year and continue to provide best-in-class solutions.
ORCL: 40.83 (+0.82)
Stull, Stull & Brody is Investigating Claims on Behalf of Oracle Corporation's (NYSE:ORCL) 401(k) Plan
GlobeNewswire - Fri Jun 17, 5:05PM CDT
Stull, Stull & Brody today announced that a securities fraud complaint has been filed and that it has commenced an investigation relating to the 401(k) defined contribution plan of Oracle Corporation (NYSE:ORCL) ("Oracle" or the "Company"
ORCL: 40.83 (+0.82)
Top Stock Research Reports for June 17, 2016
Sheraz Mian - Zacks Investment Research - Fri Jun 17, 5:04PM CDT
Top Stock Research Reports for June 17, 2016
CENT: 22.30 (-0.04), MON: 109.15 (+1.99), DIS: 99.02 (+0.23), TWTR: 17.04 (+0.91), DOW: 53.68 (+0.46), ORCL: 40.83 (+0.82)
What Will the Q2 Earnings Season Bring?
Sheraz Mian - Zacks Investment Research - Fri Jun 17, 3:47PM CDT
What Will the Q2 Earnings Season Bring?
FDX: 157.89 (+1.38), AZO: 762.77 (+6.47), COST: 157.03 (-1.09), ADBE: 96.21 (+2.20), ORCL: 40.83 (+0.82)
Alphabet slips, Elizabeth Arden and Lumber Liquidators rise
AP - Fri Jun 17, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday:
FNSR: 18.94 (+0.64), RDEN: 13.80 (+0.05), GOOGL: 714.87 (+4.40), LL: 15.78 (+0.36), GOOG: 701.87 (+4.41), ORCL: 40.83 (+0.82), SWHC: 25.33 (-0.15)
Oracle Set to Possibly Pullback After Yesterday's Rally of 2.72%
Comtex SmarTrend(R) - Fri Jun 17, 11:55AM CDT
Oracle (NASDAQ:ORCL) traded in a range yesterday that spanned from a low of $38.92 to a high of $39.85. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $38.98 on volume of 16.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ORCL: 40.83 (+0.82)